ABL Bio (Korea) Top Management

298380 Stock  KRW 27,850  800.00  2.96%   
ABL Bio employs about 7 people. The company is managed by 7 executives with a total tenure of roughly 17 years, averaging almost 2.0 years of service per executive, having 1.0 employees per reported executive. Analysis of ABL Bio's management performance can provide insight into the company performance.
Jung Kim  Insider
MD COO
Jaecheon Lee  Insider
MD CFO
  
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in ABL Bio. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.

ABL Bio Management Team Effectiveness

The company has return on total asset (ROA) of (0.3051) % which means that it has lost $0.3051 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 5.5983 %, meaning that it generated $5.5983 on every $100 dollars invested by stockholders. ABL Bio's management efficiency ratios could be used to measure how well ABL Bio manages its routine affairs as well as how well it operates its assets and liabilities.

ABL Bio Workforce Comparison

ABL Bio is number one stock in number of employees category among its peers. The total workforce of Biotechnology industry is presently estimated at about 130. ABL Bio holds roughly 7.0 in number of employees claiming about 5% of stocks in Biotechnology industry.

ABL Bio Benchmark Summation

Operator
The output start index for this execution was zero with a total number of output elements of sixty-one. ABL Bio Price Series Summation is a cross summation of ABL Bio price series and its benchmark/peer.

ABL Bio Notable Stakeholders

An ABL Bio stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as ABL Bio often face trade-offs trying to please all of them. ABL Bio's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting ABL Bio's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.

About ABL Bio Management Performance

The success or failure of an entity such as ABL Bio often depends on how effective the management is. ABL Bio management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of ABL management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the ABL management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
ABL Bio Inc., a biotech research company, focuses on the development of therapeutic drugs for immuno-oncology and neurodegenerative diseases. Its pipeline drugs include ABL001, cancer immunotherapy, ADC, and ABL301. ABL Bio is traded on Korean Securities Dealers Automated Quotations in South Korea.
Please note, the presentation of ABL Bio's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, ABL Bio's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of ABL Bio's management manipulating its earnings.

ABL Bio Workforce Analysis

Traditionally, organizations such as ABL Bio use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare ABL Bio within its industry.

ABL Bio Manpower Efficiency

Return on ABL Bio Manpower

Revenue Per Employee761.7M
Revenue Per Executive761.7M
Net Loss Per Employee6.2B
Net Loss Per Executive6.2B

Complementary Tools for ABL Stock analysis

When running ABL Bio's price analysis, check to measure ABL Bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy ABL Bio is operating at the current time. Most of ABL Bio's value examination focuses on studying past and present price action to predict the probability of ABL Bio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move ABL Bio's price. Additionally, you may evaluate how the addition of ABL Bio to your portfolios can decrease your overall portfolio volatility.
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites